Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;141(4):493e-499e.
doi: 10.1097/PRS.0000000000004205.

Trends in Physician Payments for Breast Reconstruction

Affiliations

Trends in Physician Payments for Breast Reconstruction

Clifford C Sheckter et al. Plast Reconstr Surg. 2018 Apr.

Erratum in

Abstract

Background: Prosthetic breast reconstruction rates have risen in the United States, whereas autologous techniques have stagnated. Meanwhile, single-institution data demonstrate that physician payments for prosthetic reconstruction are rising, while payments for autologous techniques are unchanged. This study aims to assess payment trends and variation for tissue expander and free flap breast reconstruction.

Methods: The Blue Health Intelligence database was queried from 2009 to 2013, identifying women with claims for breast reconstruction. Trends in the incidence of surgery and physician reimbursement were characterized by method and year using regression models.

Results: There were 21,259 episodes of breast reconstruction, with a significant rise in tissue expander cases (incidence rate ratio, 1.09; p < 0.001) and an unchanged incidence of free flap cases (incidence rate ratio, 1.02; p = 0.222). Bilateral tissue expander cases reimbursed 1.32 times more than unilateral tissue expanders, whereas bilateral free flaps reimbursed 1.61 times more than unilateral variants. The total growth in adjusted tissue expander mean payments was 6.5 percent (from $2232 to $2378) compared with -1.8 percent (from $3858 to $3788) for free flaps. Linear modeling showed significant increases for tissue expander reimbursements only. Surgeon payments varied more for free flaps (the 25th to 75th percentile interquartile range was $2243 for free flaps versus $987 for tissue expanders).

Conclusions: The incidence of tissue expander cases and reimbursements rose over a period where the incidence of free flap cases and reimbursements plateaued. Reasons for stagnation in free flaps are unclear; however, the opportunity cost of performing this procedure may incentivize the alternative technique. Greater payment variation in autologous reconstruction suggests the opportunity for negotiation with payers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Yearly Incidence of Breast Reconstruction by Method and Laterality. Bar graph demonstrating yearly incidence of breast reconstruction parsed by method and laterality
Figure 2
Figure 2
Adjusted Physician Payment Distributions by Method and Year. Yearly percentiles for physician payments. Bilateral payments are adjusted to unilateral for normalized comparison. Whiskers represent 5th and 95th percentiles; boxes represent 25th and 75th percentiles; and hash lines represent medians.
Figure 3
Figure 3
Linear Modeling of Breast Reconstruction Incidence & Median Physican Payment. Scatter plot of breast reconstruction incidence versus median physician payment with linear model. FF, free flaps represented with red squares. TE, tissue expanders represented with blue dots. Median physician payments are adjusted for laterality such that bilateral cases are transformed into unilateral equivalent payment. P-value represents significance of linear model.

Similar articles

Cited by

References

    1. Albornoz CR, Bach PB, Mehrara BJ, Disa JJ, Pusic AL, McCarthy CM, et al. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013 Jan;131(1):15–23. - PubMed
    1. Farhangkhoee H, Matros E, Disa J. Trends and concepts in post-mastectomy breast reconstruction. J Surg Oncol. 2016 Jun;113(8):891–4. - PMC - PubMed
    1. Albornoz CR, Cordeiro PG, Pusic AL, McCarthy CM, Mehrara BJ, Disa JJ, et al. Diminishing relative contraindications for immediate breast reconstruction: a multicenter study. J Am Coll Surg. 2014 Oct;219(4):788–95. - PubMed
    1. Alderman AK, Storey AF, Nair NS, Chung KC. Financial Impact of Breast Reconstruction on an Academic Surgical Practice. Plast Reconstr Surg. 2009 May;123(5):1408–13. - PMC - PubMed
    1. [cited 2017 Apr 21];Blue Health Intelligence [Internet] Available from: https://bluehealthintelligence.com/markets/life-sciences/index.html.

MeSH terms